Lantern Pharma Uses AI to Cut Cancer Drug Costs and Speed Trials With RADAR Platform

Lantern Pharma is transforming cancer drug development using its AI-powered RADAR platform, analyzing massive datasets to identify effective treatments faster and at a fraction of traditional costs. The company has built a pipeline of 12 programs with multiple clinical trials, achieving drug development timelines measured in months instead of years.

With precision oncology strategies, strong clinical results, and partnerships with leading institutions, Lantern is advancing therapies for underserved cancers while expanding its AI tools to accelerate discovery across the industry. The company’s approach aims to dramatically improve success rates and efficiency in oncology innovation.

#LanternPharma
#ArtificialIntelligence
#CancerResearch
#Biotech
#DrugDevelopment
#ClinicalTrials
#PrecisionMedicine
#Oncology
#AIinHealthcare
#MedicalInnovation
#BiotechInvesting
#HealthcareTechnology
#Pharmaceuticals
#Nasdaq
#NewsOut